Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Human data are limited and mixed: Clinical studies have largely assessed safety and metabolism, while weight-related outcomes were modest and inconsistent
The FDA classified BPC-157 as a Category 2 bulk drug substance in 2023, meaning it cannot be compounded by commercial pharmaceutical companies and there is insufficient evidence regarding potential human harm
If you move from a 10mg vial with 2ml of water to a 30mg vial with 3ml of water, the units per dose change completely
Dihexa (PNB-0408) (N-hexanoic-Tyr-Ile-(6)-amino hexanoic amide) is an oral active, blood-brain barrier-permeable angiotensin IV analogue
Whether you are recovering from a sports injury, surgery, or managing chronic pain, BPC-157 can be a powerful tool to accelerate healing and improve your overall well-being
Common formulations include 5mg, 10mg, 15mg, and 30mg vials
US$ 25.29
US$ 29.79
US$ 20.65
US$ 27.48
